Scarica l'app Stockscreener
6.75
9.76%
0.60
Dopo l'orario di chiusura:
6.70
-0.05
-0.74%
Sagimet Biosciences Inc Borsa (SGMT) Ultime notizie
Roche deal to buy 89bio boosts MASH space (ETNB:NASDAQ) - Seeking Alpha
Sagimet Biosciences Inc.Positive Phase 3 Results for Denifanstat for the Treatment of Moderate to Severe Acne to be presented at the EADV Congress 2025 by Partner Ascletis - MarketScreener
Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives $25.67 Average Price Target from Brokerages - MarketBeat
Wall Street Zen Downgrades Sagimet Biosciences (NASDAQ:SGMT) to Sell - MarketBeat
Positive Phase 3 Results For Denifanstat For The Treatment Of Moderate To Severe Acne To Be Presented At The Eadv Congress 2025 By Partner Ascletis - TradingView
Positive Phase 3 Results for Denifanstat for the Treatment of Moderate to Severe Acne to be Presented at the EADV Congress 2025 by Partner Ascletis - The Manila Times
Sagimet Biosciences Reports Successful Phase 3 Trial Results for Denifanstat in Acne Treatment and Announces Phase 1 Trial of TVB-3567 - Quiver Quantitative
Positive Phase 3 Results for Denifanstat for the Treatment - GlobeNewswire
18.6% Treatment Success: Sagimet's Novel FASN Inhibitor Achieves Breakthrough in Phase 3 Acne Trial - Stock Titan
Sagimet Biosciences Inc.'s (NASDAQ:SGMT) market cap dropped US$22m last week; individual investors who hold 46% were hit as were institutions - simplywall.st
Aug Ideas: Is Sagimet Biosciences Inc stock trending bullish2025 Biggest Moves & Advanced Swing Trade Entry Alerts - خودرو بانک
Ideas Watch: Will GRFS outperform its industry peers2025 Investor Takeaways & Technical Pattern Alert System - خودرو بانک
Aug Mood: Can Sagimet Biosciences Inc continue delivering strong returnsWeekly Gains Report & Real-Time Volume Surge Alerts - خودرو بانک
Here's Why Sagimet Biosciences Inc. (SGMT) is Poised for a Turnaround After Losing 15.8% in 4 Weeks - Yahoo Finance
Aug EndMonth: Is Sagimet Biosciences Inc. stock a buy or sell2025 Winners & Losers & Free Expert Verified Stock Movement Alerts - خودرو بانک
Dow Update: Is Sagimet Biosciences Inc. stock a good pick for beginners2025 Fundamental Recap & High Accuracy Investment Entry Signals - خودرو بانک
Market Leaders: Can Sagimet Biosciences Inc. continue delivering strong returnsEntry Point & Fast Gain Stock Trading Tips - خودرو بانک
Quarterly Risk: Is Sagimet Biosciences Inc stock influenced by commodity pricesJuly 2025 Chart Watch & Intraday High Probability Setup Alerts - خودرو بانک
Is Sagimet Biosciences Inc. stock entering bullish territory2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - newser.com
What earnings revisions data tells us about Sagimet Biosciences Inc.2025 Biggest Moves & Smart Money Movement Tracker - newser.com
Applying big data sentiment scoring on Sagimet Biosciences Inc.2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
What momentum shifts mean for Sagimet Biosciences Inc.July 2025 Short Interest & Weekly Top Gainers Alerts - newser.com
Will Sagimet Biosciences Inc. continue its uptrendWeekly Market Summary & Comprehensive Market Scan Insights - newser.com
Will Sagimet Biosciences Inc. benefit from macro trendsWeekly Investment Recap & Weekly Return Optimization Plans - newser.com
will sagimet biosciences inc. continue its uptrendJuly 2025 Trade Ideas & Verified Short-Term Trading Plans - newser.com
Ranking Sagimet Biosciences Inc. among high performing stocks via toolsJobs Report & Smart Swing Trading Alerts - newser.com
Visual analytics tools that track Sagimet Biosciences Inc. performanceMarket Volume Report & Weekly Top Stock Performers List - newser.com
Should you wait for a breakout in Sagimet Biosciences Inc.July 2025 Summary & Risk Managed Investment Signals - newser.com
Can volume confirm reversal in Sagimet Biosciences Inc.July 2025 Retail & Capital Efficiency Focused Ideas - Newser
Forecasting Sagimet Biosciences Inc. price range with options data2025 Market Sentiment & Reliable Intraday Trade Alerts - Newser
What’s the recovery path for long term holders of Sagimet Biosciences Inc.Earnings Miss & Consistent Profit Trading Strategies - Newser
Does Sagimet Biosciences Inc. qualify in momentum factor screeningWeekly Loss Report & Community Verified Swing Trade Signals - Newser
Real time social sentiment graph for Sagimet Biosciences Inc.Global Markets & Risk Controlled Daily Plans - Newser
How to track smart money flows in Sagimet Biosciences Inc.Quarterly Profit Summary & Daily Volume Surge Signals - Newser
Will Sagimet Biosciences Inc. stock go up soonMarket Growth Report & Expert Approved Momentum Trade Ideas - Newser
Sagimet Biosciences (NASDAQ:SGMT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Alyeska Investment Group L.P. Trims Stock Position in Sagimet Biosciences Inc. $SGMT - MarketBeat
Sagimet Biosciences to Present at the 9th Annual MASH Drug Development Summit on Innovations in Metabolic Dysfunction and Fibrosis Treatment - Quiver Quantitative
Sagimet Biosciences Announces Upcoming Presentations at 9th Annual MASH Drug Development Summit - GlobeNewswire
Novel MASH Treatment Data: Sagimet's Denifanstat Shows Anti-Fibrotic Effects in Advanced Patients - Stock Titan
Price action breakdown for Sagimet Biosciences Inc.July 2025 Big Picture & Smart Allocation Stock Tips - Newser
Will Sagimet Biosciences Inc. Benefit From Broader Market BounceJuly 2025 Setups & Daily Entry Point Trade Alerts - beatles.ru
Can Sagimet Biosciences Inc. continue delivering strong returnsJuly 2025 Closing Moves & Comprehensive Market Scan Reports - beatles.ru
Wall Street Zen Upgrades Sagimet Biosciences (NASDAQ:SGMT) to “Hold” - Defense World
Is Sagimet Biosciences Inc. attractive at current valuation2025 Volume Leaders & Weekly Watchlist of Top Performers - خودرو بانک
Sagimet Biosciences shares fall 1.55% after-hours following presentation at Cantor Global Healthcare Conference. - AInvest
What indicators show strength in Sagimet Biosciences Inc.July 2025 Analyst Calls & Safe Capital Growth Plans - Newser
Sagimet Biosciences’ Strategic Positioning in the Biotech Sector - AInvest
Sagimet Biosciences Presents at Cantor Global Healthcare Conference 2025 - AInvest
Transcript : Sagimet Biosciences Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-03-2025 01 - MarketScreener
Sagimet Biosciences Inc.’s volatility index tracking explainedWeekly Trade Report & Smart Investment Allocation Tips - Newser
Is Sagimet Biosciences Inc. stock bottoming outGlobal Markets & Risk Adjusted Swing Trade Ideas - Newser
Is Sagimet Biosciences Inc. a strong candidate for buy and hold2025 Retail Activity & Smart Allocation Stock Tips - خودرو بانک
News impact scoring models applied to Sagimet Biosciences Inc.Portfolio Gains Summary & Daily Growth Stock Investment Tips - Newser
0.25%
0.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):